IP Library › Assignment 062582/0873
Patent Assignment
Reel/Frame 062582/0873

Release of Security Interest

Recorded: 2023-02-03 Pages: 7
Assignor
Assignee
OYSTER POINT PHARMA INC.
202 CARNEGIE CENTER DRIVE, SUITE 109, PRINCETON, NEW JERSEY, 08540
Covered Properties (35)
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application: 17/144,884 →
Publication: US 2021/0371401
Methods of Increasing Lacrimal Proteins
Application: 16/566,237 →
Publication: US 2020/0246336
Combinations of Positive Allosteric Modulators and Nicotinic Acetylcholine Receptor Agonists for Treating Ocular Conditions
Application: 17/144,548 →
Publication: US 2021/0379066
Aav Virion Encoding Neurotrophic Factor and Uses Thereof
Application: 63/185,889 →
Co-Therapy with Vector and Nicotinic Agonist
Application: 63/185,897 →
Nesting Structures for Storage, Transport, and Assembly of Drug Dispensers and Containers
Application: 17/150,905 →
Publication: US 2022/0227566
Compositions and Use of Varenicline for Treating Dry Eye
Application: 17/543,505 →
Publication: US 2022/0233528
Aav Virion Encoding Diamine Oxidase and Uses Thereof
Application: 63/348,856 →
Nasal Spray Guide
Application: 17/829,286 →
Publication: US 2023/0381800
Nasal Spray Guide
Patent: 1,055,276 →
Application: 29/840,754 →
Nasal Spray Guide
Patent: 1,055,277 →
Application: 29/840,756 →
Dispenser Configured for Aseptic Transfer of a Liquid Product
Application: 17/889,285 →
Publication: US 2024/0058216
Aav Virion Encoding Oxidoreductase Enzyme and Uses Thereof
Application: 63/375,613 →
Drug Transfer System Configured for Aseptic Transfer of Liquid Product
Application: 63/398,494 →
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application: 18/061,354 →
Publication: US 2023/0295126
Local Administration of Nicotinic Acetylcholine Receptor Agonists for the Inhibition of Coronavirus Infections
Application: 18/049,815 →
Publication: US 2023/0210861
Aav Virion Encoding Diamine Oxidase and Uses Thereof
Application: 63/383,026 →
Aav Virion Encoding Oxidoreductase Enzyme and Uses Thereof
Application: 63/383,055 →
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3YLVINYL)Pyrimidine
Patent: 8,604,191 →
Application: 13/129,898 →
Publication: US 2011/0281895
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3YLVINYL)Pyrimidine
Patent: 9,145,396 →
Application: 14/074,147 →
Publication: US 2014/0066460
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Patent: 9,981,949 →
Application: 15/354,832 →
Publication: US 2017/0260167
Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application: 15/962,982 →
Publication: US 2019/0071428
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application: 16/541,033 →
Publication: US 2020/0207740
Novel Compounds
Patent: 8,153,821 →
Application: 13/130,954 →
Publication: US 2011/0269975
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 7,098,331 →
Application: 10/379,868 →
Publication: US 2004/0176348
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 7,714,001 →
Application: 12/187,584 →
Publication: US 2008/0293778
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 8,063,068 →
Application: 12/348,605 →
Publication: US 2010/0010042
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 8,067,443 →
Application: 12/683,106 →
Publication: US 2010/0267776
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Patent: 8,633,222 →
Application: 13/033,719 →
Publication: US 2011/0152293
Methods of Increasing Tear Production
Patent: 9,504,644 →
Application: 14/887,243 →
Publication: US 2016/0106744
Dry Eye Treatments
Patent: 9,597,284 →
Application: 14/887,248 →
Publication: US 2016/0106745
Methods of Improving Ocular Discomfort
Patent: 9,532,944 →
Application: 14/887,253 →
Publication: US 2016/0106665
Pharmaceutical Formulations for Treating Ocular Conditions
Patent: 9,504,645 →
Application: 14/887,259 →
Publication: US 2016/0106746
Dry Eye Treatments
Application: 15/422,382 →
Publication: US 2017/0239244
Methods of Treating Ocular Conditions
Application: 16/091,830 →
Publication: US 2019/0201397
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 17, 2016
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 040645/0282 →
Change of Name Nov 17, 2016
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 040645/0359 →
Assignment of Assignor's Interest Nov 17, 2016
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 040364/0118 →
Assignment of Assignor's Interest Jan 9, 2017
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 040904/0482 →
Assignment of Assignor's Interest Jan 13, 2017
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041043/0769 →
Change of Name Jan 13, 2017
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 041044/0211 →
Change of Name Apr 27, 2018
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 046035/0452 →
Assignment of Assignor's Interest Apr 27, 2018
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 045661/0119 →
Assignment of Assignor's Interest Apr 27, 2018
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 046033/0403 →
Assignment of Assignor's Interest Aug 14, 2019
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 050058/0270 →
Assignment of Assignor's Interest Aug 14, 2019
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 050058/0184 →
Change of Name Aug 14, 2019
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 050058/0264 →
Assignment of Assignor's Interest May 6, 2020
From: ACKERMANN, DOUGLAS MICHAEL, JR.; LOUDIN, JAMES; MANDELL, KENNETH J.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 052588/0291 →
Assignment of Assignor's Interest Jan 8, 2021
From: NAU, JEFFREY ALAN
To: OYSTER POINT PHARMA, INC.
Reel/Frame 054862/0181 →
Change of Name Jan 11, 2021
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 055226/0671 →
Assignment of Assignor's Interest Jan 11, 2021
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 054960/0420 →
Assignment of Assignor's Interest Jan 11, 2021
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 054960/0591 →
Assignment of Assignor's Interest Mar 17, 2021
From: NAU, JEFFREY ALAN; DONATO, GEORGE J.; BUEL, TRAVIS D.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 055629/0955 →
Assignment of Assignor's Interest Mar 17, 2021
From: GILERO, LLC
To: OYSTER POINT PHARMA, INC.
Reel/Frame 055629/0941 →
Assignment of Assignor's Interest Mar 17, 2021
From: MCCALL, CHARLES E., JR.; RANALLETTA, JOSEPH VINCENT
To: GILERO, LLC
Reel/Frame 055629/0923 →
Assignment of Assignor's Interest Aug 4, 2021
From: NAU, JEFFREY ALAN
To: OYSTER POINT PHARMA, INC.
Reel/Frame 057083/0878 →
Assignment of Assignor's Interest Aug 4, 2021
From: NAU, JEFFREY ALAN
To: OYSTER POINT PHARMA, INC.
Reel/Frame 057083/0871 →
Patent Security Agreement Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Corrective Assignment to Correct the the Conveying Party Execution Date Previously Recorded at Reel: 041044 Frame: 0211. Assignor(S) Hereby Confirms the Assignment. Oct 26, 2021
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 057923/0518 →
Assignment of Assignor's Interest Dec 7, 2021
From: ACKERMANN, DOUGLAS MICHAEL, JR.; LOUDIN, JAMES; MANDELL, KENNETH J.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 058324/0782 →